Virtual screening and in vitro experimental verification of LuxS inhibitors from natural products for Lactobacillus reuteri
Fanying Meng(Hunan University of Traditional Chinese Medicine), Jie Yu(Yunnan University of Traditional Chinese Medicine), Fan Zhang(Tufts University), Wen Gu(Yunnan University of Traditional Chinese Medicine), Min Yang(Kunming Third People's Hospital), Xue Li(Fudan University), Yaqin Yang(Yunnan University), Qiuding Chen(Yunnan University)
Cited by 25
Related Papers
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
|Molecular Cancer Therapeutics|2011|206
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL
|Clinical Cancer Research|2019|53
Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer
|Cancer Biology & Therapy|2015|51
Potent Antitubulin Tumor Cell Cytotoxins Based on 3-Aroyl Indazoles
|Journal of Medicinal Chemistry|2007|50